Compare Ferrari NV (RACE) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ferrari NV vs Tempus AI — how do they compare? Ferrari NV trades at $409.61 (market cap $70.66B), while Tempus AI trades at $60.36 (market cap $11.13B). The key difference: Ferrari NV is far larger — about 6.3× Tempus AI's market cap, and Ferrari NV pays a 1.05% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| RACE | TEM | |
|---|---|---|
Market Cap | $70.66B | $11.13B |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $504.09 | $103.25 |
52-Week Low | $314.63 | $41.55 |
Enterprise Value | $72.61B | $11.75B |
Dividend Yield | 1.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ferrari (RACE) trades at $405.94, down 0.98% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $5.1B in 2022 to $7.1B in 2025, and robust profitability margins. Recent news highlights a record $40 million auction of its first electric car, reinforcing brand prestige. Analyst consensus is bullish with a $462.67 price target, though technical indicators suggest near-term pressure with support at $402 and resistance at $411.
The outlook remains positive due to Ferrari's pricing power and margin strength, but risks include high valuation multiples and economic sensitivity. Institutional buying and share repurchases provide support, yet investors face volatility from technical bearishness and competitive pressures in the luxury auto sector.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company reported a net loss of $245.03M in 2025 despite revenue of $1.27B, but recent quarterly EPS beats and FDA clearance for an AI-enabled ECG product (Business Wire, 2026-08-24) highlight growth potential in precision medicine. Analyst consensus is strongly bullish with a $69.20 price target.
Outlook: TEM's AI-driven healthcare platform positions it for long-term growth amid industry shifts toward personalized medicine, though persistent losses and high P/B of 25.01 pose valuation risks. Near-term catalysts include continued execution on recent contracts and pipeline developments, but investors face volatility from cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
